Allogene Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
30 Jan 24 | BuyUS$683 | Geoffrey Parker | Individual | 190 | US$3.60 | |
07 Aug 23 | SellUS$42,855 | Stephen Mayo | Individual | 10,000 | US$4.29 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 59,274 | 0.0347% |
Individual Insiders | 11,856,654 | 6.94% |
General Public | 13,170,605 | 7.71% |
VC/PE Firms | 18,716,306 | 11% |
Public Companies | 22,032,040 | 12.9% |
Institutions | 104,888,221 | 61.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
25,241,499 | US$69.7m | 0.39% | no data | |||
22,032,040 | US$60.8m | 0% | no data | |||
18,716,306 | US$51.7m | 0% | 0.18% | |||
10,001,804 | US$27.6m | 12.5% | no data | |||
9,030,825 | US$24.9m | -14.7% | no data | |||
6,620,816 | US$18.3m | -0.94% | no data | |||
5,337,677 | US$14.7m | 4.49% | no data | |||
5,281,886 | US$14.6m | -0.05% | 0.01% | |||
5,227,123 | US$14.4m | 6.01% | no data | |||
4,053,226 | US$11.2m | -1.52% | 0.01% | |||
2,984,226 | US$8.2m | 190% | no data | |||
2,577,500 | US$7.1m | -51.5% | 0.08% | |||
2,427,284 | US$6.7m | -70.4% | no data | |||
2,371,472 | US$6.5m | -1.49% | no data | |||
2,335,195 | US$6.4m | 12.7% | no data | |||
2,314,541 | US$6.4m | 78% | 0.02% | |||
1,920,787 | US$5.3m | 0% | 1.19% | |||
1,919,014 | US$5.3m | 1,440% | no data | |||
1,798,163 | US$5.0m | 0% | 3.8% | |||
1,535,245 | US$4.2m | -16.5% | no data | |||
1,277,700 | US$3.5m | 30.8% | 0.01% | |||
1,271,616 | US$3.5m | 24.8% | no data | |||
1,014,345 | US$2.8m | 17.9% | no data | |||
898,049 | US$2.5m | 319% | 0.01% | |||
775,093 | US$2.1m | 61.4% | 0.11% |